Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test could spare thousands from unnecessary breast cancer treatment
Disease control Recruiting nowThis study is testing whether a simple blood test that looks for cancer DNA can help doctors decide when to start a targeted therapy (CDK4/6 inhibitor) in people with intermediate-risk HR+ HER2- breast cancer. About 725 participants will have their blood tested every 3 months for…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Jun 23, 2026 23:31 UTC
-
New blood test could spot genetic diseases before birth
Diagnosis Recruiting nowThis study is working on a new blood test for pregnant women that can check for serious genetic conditions like cystic fibrosis, spinal muscular atrophy, and sickle cell disease. Researchers will collect blood samples from 4,000 pregnant women who are at higher risk of passing on…
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated Jun 22, 2026 12:03 UTC
-
Blood test could replace colonoscopy for cancer screening?
Diagnosis Recruiting nowThis study is testing a new blood test from Natera to see how well it can detect colorectal cancer and advanced growths in people at average risk. About 25,000 adults aged 40 and older who are already scheduled for a colonoscopy will give a blood sample. The results will be compa…
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated Jun 17, 2026 12:08 UTC
-
Blood and tissue samples sought to refine cancer DNA tests
Knowledge-focused Recruiting nowThis study collects blood and leftover tissue samples from 9,600 people with various cancers, including breast, lung, and pancreatic cancer. Researchers will use these samples to improve tests that look for cancer DNA in the blood. The goal is to better detect if cancer returns o…
Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC